uracil has been researched along with Central Nervous System Disease in 3 studies
2,4-dihydroxypyrimidine: a urinary biomarker for bipolar disorder
| Excerpt | Relevance | Reference |
|---|---|---|
| " 3,5-diiodothyronine (T2) has been used with success in rat models of dyslipidemia and NAFLD, but the outcome of a clinical trial with a synthetic T2 analogue was disappointing." | 5.05 | Thyroid Hormone Analogues: An Update. ( Zucchi, R, 2020) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (33.33) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Zucchi, R | 1 |
| Assmann, BE | 1 |
| Van Kuilenburg, AB | 1 |
| Distelmaier, F | 1 |
| Abeling, NG | 1 |
| Rosenbaum, T | 1 |
| Schaper, J | 1 |
| Duran, M | 1 |
| Mayatepek, E | 1 |
| Davis, ST | 1 |
| Joyner, SS | 1 |
| Baccanari, DP | 1 |
| Spector, T | 1 |
1 review available for uracil and Central Nervous System Disease
| Article | Year |
|---|---|
Thyroid Hormone Analogues: An Update.
Topics: Acetates; Anilides; Animals; Central Nervous System Diseases; Clinical Trials as Topic; Diiodothyron | 2020 |
2 other studies available for uracil and Central Nervous System Disease
| Article | Year |
|---|---|
Beta-ureidopropionase deficiency presenting with febrile status epilepticus.
Topics: Amidohydrolases; Atrophy; Central Nervous System Diseases; Diagnosis, Differential; Fever; Hematoma, | 2006 |
5-Ethynyluracil (776C85): protection from 5-fluorouracil-induced neurotoxicity in dogs.
Topics: Animals; beta-Alanine; Central Nervous System Diseases; Dihydrouracil Dehydrogenase (NADP); Dogs; Do | 1994 |